2023 Q1 Form 10-K Financial Statement

#000106299323008192 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $794.0K $268.0K $3.046M
YoY Change 34.12% -66.63% 57.58%
% of Gross Profit
Research & Development $1.250M $4.302M $4.302M
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $722.0K $1.333M $4.111M
YoY Change 21.96% 72.89% 112.67%
Operating Profit -$805.0K -$4.255M
YoY Change -44.52% -36.03%
Interest Expense $83.00K -$496.0K $144.0K
YoY Change 56.6% 713.11% -29.41%
% of Operating Profit
Other Income/Expense, Net -$1.311M $0.00 $2.327M
YoY Change 358.39% -100.0% -279.69%
Pretax Income -$2.116M -$812.0K -$1.928M
YoY Change 156.48% -27.37% -36.24%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.116M -$700.0K -$1.928M
YoY Change 156.48% -37.39% -36.24%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.01
Diluted Earnings Per Share -$0.01 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 309.6M shares 304.5M shares
Diluted Shares Outstanding 309.6M shares 304.5M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.60M $1.365M $1.365M
YoY Change 5225.13% 62.11% 62.11%
Cash & Equivalents $10.60M $1.365M $1.365M
Short-Term Investments
Other Short-Term Assets $100.0K $56.00K $56.00K
YoY Change 112.77% 30.23% 30.23%
Inventory
Prepaid Expenses
Receivables
Other Receivables $11.00K $7.000K
Total Short-Term Assets $10.71M $1.428M $1.428M
YoY Change 4115.75% 60.27% 60.27%
LONG-TERM ASSETS
Property, Plant & Equipment $7.884M $7.884M $7.884M
YoY Change -76.32% -75.52% -75.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.467M $1.504M $1.504M
YoY Change
Other Assets $23.00K $23.00K $23.00K
YoY Change -34.29% -34.29% -34.29%
Total Long-Term Assets $9.374M $9.411M $9.411M
YoY Change -71.87% -70.81% -70.81%
TOTAL ASSETS
Total Short-Term Assets $10.71M $1.428M $1.428M
Total Long-Term Assets $9.374M $9.411M $9.411M
Total Assets $20.08M $10.84M $10.84M
YoY Change -40.2% -67.28% -67.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $593.0K $232.0K $232.0K
YoY Change -69.1% -82.92% -82.92%
Accrued Expenses $22.00K $4.000K $4.000K
YoY Change -99.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.996M
YoY Change
Total Short-Term Liabilities $10.77M $1.984M $1.984M
YoY Change 456.17% 40.41% 40.41%
LONG-TERM LIABILITIES
Long-Term Debt $813.0K $1.874M $1.874M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $813.0K $1.874M $1.874M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.77M $1.984M $1.984M
Total Long-Term Liabilities $813.0K $1.874M $1.874M
Total Liabilities $11.59M $3.858M $4.246M
YoY Change 498.14% 173.04% 200.5%
SHAREHOLDERS EQUITY
Retained Earnings -$123.8M -$121.8M
YoY Change 1.51%
Common Stock $105.4M $105.4M
YoY Change 1.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.735M $6.593M $6.593M
YoY Change
Total Liabilities & Shareholders Equity $20.08M $10.84M $10.84M
YoY Change -40.2% -67.28% -67.28%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$2.116M -$700.0K -$1.928M
YoY Change 156.48% -37.39% -36.24%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $5.826M $2.598M -$1.786M
YoY Change -1326.53% -408.55% -14.05%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $371.0K $1.062M
YoY Change -100.0% -118.78% -127.24%
Acquisitions
YoY Change
Other Investing Activities -$3.997M $508.0K
YoY Change -72.24%
Cash From Investing Activities $0.00 -$4.368M -$554.0K
YoY Change -100.0% 121.16% -73.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.406M 888.0K $2.863M
YoY Change -48.58% -33.25%
NET CHANGE
Cash From Operating Activities $5.826M 2.598M -$1.786M
Cash From Investing Activities $0.00 -4.368M -$554.0K
Cash From Financing Activities $3.406M 888.0K $2.863M
Net Change In Cash $9.232M -882.0K $523.0K
YoY Change -1535.77% -19.08% 268.31%
FREE CASH FLOW
Cash From Operating Activities $5.826M $2.598M -$1.786M
Capital Expenditures $0.00 $371.0K $1.062M
Free Cash Flow $5.826M $2.227M -$2.848M
YoY Change -1997.72% 96.56% -256.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1664106
CY2022 dei Auditor Location
AuditorLocation
Vancouver, Canada
CY2022 dei Auditor Name
AuditorName
MNP LLP
CY2022 dei Auditor Firm
AuditorFirmId
1930
CY2022 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 usd
CY2021 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
189000 usd
CY2021 lcgmf Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
323000 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
27000 usd
CY2021 lcgmf Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
4128000 usd
CY2021 lcgmf Stockholder Equity Fair Value Of Warrants
StockholderEquityFairValueOfWarrants
0 usd
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
162000 usd
CY2022 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 usd
CY2021 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
189000 usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
830000 usd
CY2021Q4 us-gaap Cash
Cash
842000 usd
CY2020Q4 us-gaap Cash
Cash
701000 usd
CY2022Q4 us-gaap Cash
Cash
1365000 usd
CY2021Q4 us-gaap Cash
Cash
842000 usd
CY2021 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
87000 usd
CY2021Q1 us-gaap Cash
Cash
701000 usd
CY2021Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3000 usd
CY2021Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
641000 usd
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5000 usd
CY2021Q1 us-gaap Assets Current
AssetsCurrent
1350000 usd
CY2021Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
6278000 usd
CY2021Q1 us-gaap Restricted Investments
RestrictedInvestments
34000 usd
CY2021Q1 us-gaap Assets
Assets
7662000 usd
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
222000 usd
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
222000 usd
CY2021Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
51000 usd
CY2021Q1 us-gaap Liabilities
Liabilities
273000 usd
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
101553000 usd
CY2021Q1 lcgmf Contributed Surplus
ContributedSurplus
0 usd
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19406000 usd
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-113570000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
7389000 usd
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7662000 usd
CY2021Q4 us-gaap Cash
Cash
842000 usd
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
6000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
891000 usd
CY2021Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
6821000 usd
CY2021Q4 us-gaap Restricted Investments
RestrictedInvestments
35000 usd
CY2021Q4 us-gaap Assets
Assets
7747000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1358000 usd
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
55000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1413000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
104340000 usd
CY2021Q4 lcgmf Contributed Surplus
ContributedSurplus
0 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22012000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-120018000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6334000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7747000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
58000 usd
CY2021 us-gaap General Insurance Expense
GeneralInsuranceExpense
30000 usd
CY2021 us-gaap Business Development
BusinessDevelopment
206000 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
493000 usd
CY2021 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
13000 usd
CY2021 us-gaap Salaries And Wages
SalariesAndWages
938000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1077000 usd
CY2021 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
108000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
3010000 usd
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-4000 usd
CY2021 lcgmf Mineral Exploration Expenditures
MineralExplorationExpenditures
3642000 usd
CY2021 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
189000 usd
CY2021 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
11000 usd
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
8000 usd
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3438000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-6448000 usd
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
239831079 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
239831079 shares
CY2021Q4 us-gaap Minority Interest
MinorityInterest
0 usd
CY2022 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
500000 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-112000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
388000 usd
CY2021Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2022 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
131000 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
1874000 usd
CY2022Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
1500000 shares
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
119000 usd
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
4128000 usd
CY2021 lcgmf Number Of Common Shares Issued In Exercise Of Options And Warrants
NumberOfCommonSharesIssuedInExerciseOfOptionsAndWarrants
5885000 shares
CY2021 lcgmf Proceeds From Exercise Of Options And Warrants
ProceedsFromExerciseOfOptionsAndWarrants
323000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2394283 shares
CY2022Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.072

Files In Submission

Name View Source Status
lcgmf-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001062993-23-008192-index-headers.html Edgar Link pending
0001062993-23-008192-index.html Edgar Link pending
0001062993-23-008192.txt Edgar Link pending
0001062993-23-008192-xbrl.zip Edgar Link pending
exhibit10-1.htm Edgar Link pending
exhibit10-3.htm Edgar Link pending
exhibit19-1.htm Edgar Link pending
exhibit19-1x001.jpg Edgar Link pending
exhibit21-1.htm Edgar Link pending
exhibit3-1.htm Edgar Link pending
exhibit3-1x1x1.jpg Edgar Link pending
exhibit3-1x2x1.jpg Edgar Link pending
exhibit3-1x3x1.jpg Edgar Link pending
exhibit3-1xu001.jpg Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10k.htm Edgar Link pending
form10kx002.jpg Edgar Link pending
form10kx003.jpg Edgar Link pending
form10kx006.jpg Edgar Link pending
form10kx007.jpg Edgar Link pending
form10kxm001.jpg Edgar Link pending
form10kxm002.jpg Edgar Link pending
form10kxu001.jpg Edgar Link pending
form10kxu002.jpg Edgar Link pending
form10kxu003.jpg Edgar Link pending
form10kxu004.jpg Edgar Link pending
lcgmf-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
lcgmf-20221231_cal.xml Edgar Link unprocessable
lcgmf-20221231_def.xml Edgar Link unprocessable
lcgmf-20221231_lab.xml Edgar Link unprocessable
form10k_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending